Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia.
about
Preparation of PEG-grafted immunomagnetoliposomes entrapping citrate stabilized magnetite particles and their application in CD34+ cell sorting.Multi-functional polymeric nanoparticles for tumour-targeted drug delivery.Magnetic micro- and nano-particle-based targeting for drug and gene delivery.Optimizing magnetic nanoparticle design for nanothermotherapy.Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research.Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging.DNA as a Target for Anticancer Phen-Imidazole Pd(II) Complexes.Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studies.Enhanced anticancer therapy mediated by specialized liposomes.Enhancement of cytokine expression in transiently transfected cells by magnetoliposome mediated hyperthermia.Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer.Preparation of human immune effector T cells containing iron-oxide nanoparticles.Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study.Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes.The role of dipole interactions in hyperthermia heating colloidal clusters of densely-packed superparamagnetic nanoparticles.Multifunctional nanovectors based on magnetic nanoparticles coupled with biological vesicles or synthetic liposomes
P2860
Q32000334-F67093E3-8709-40B4-8FF1-D7CC6A7BC2EAQ36409038-2B588100-71E2-4D31-A187-2A39E1C0A20DQ36918075-25653B8D-8B84-4D72-B669-66F4A7B49C7CQ37331799-0C7C5648-981A-465E-B581-27D128A69182Q38102018-B9F781F6-FB12-4801-80A7-05BBE7D3746DQ38425098-D52E774D-FB4F-45CC-B797-803BE3722E7BQ38727006-FA9DFB2E-B84B-4940-9152-7F0DBE7FD2B5Q40431663-5EBF1DEC-29C9-464D-8D0F-BCC8CAB5D755Q41639702-F372923A-9BBC-4BD8-823A-F5B91EF23DFBQ41884825-C5AA6B39-890B-431F-BD70-81277496E5BBQ44912086-0C9BEA03-4A74-4773-877F-1CA9DFC9416FQ47627126-CE0BB530-32AB-464A-BF9B-787A235FA900Q54965829-0A9FB06C-DE19-4EDE-A246-500328ACEA0AQ54994628-CDBD3107-4234-4871-B6DB-9DA718A92B3BQ55035554-98CBEAF1-CED1-4A74-A02E-1B4ECC0B5519Q55222760-6387E3D3-0AFD-4306-9BB3-FABDCF13F02EQ57559360-A29F94E5-FBF1-499C-9226-4B53A461D028
P2860
Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@en
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@nl
type
label
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@en
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@nl
prefLabel
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@en
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@nl
P2093
P1476
Antibody-conjugated magnetolip ...... r application in hyperthermia.
@en
P2093
P304
P356
10.1111/J.1470-8744.1995.TB00329.X
P478
21 ( Pt 2)
P577
1995-04-01T00:00:00Z